Clinical outcomes stratified by baseline functional class after initial combination therapy for pulm...
Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Initial combination therapy with ambrisentan and tadalafil reduced the risk of clinical failure events for treatment-naïve participants with pulmonary arterial hypertension (PAH) as compared to monotherapy. Previous studies in PAH have demonstrated greater treatment benefits in more symptomatic participants.
AMBITION was an event-driven, double-...
Alternative Titles
Full title
Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f44fd922b4584cd3b84761a83b713dd5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f44fd922b4584cd3b84761a83b713dd5
Other Identifiers
ISSN
1465-993X,1465-9921
E-ISSN
1465-993X,1465-9921
DOI
10.1186/s12931-019-1180-1
